The news that former Giro d’Italia and Vuelta a España winner Nairo Quintana has tested positive for tramadol, resulting in his disqualification from last month’s Tour de France, has shocked a cycling world seemingly no longer used to its star names falling foul of the drug testers.
> Nairo Quintana sanctioned by UCI for tramadol infringement
According to the UCI’s statement today, the Arkéa–Samsic climber – who finished sixth at this year’s Tour – tested positive for tramadol on the days of the crucical stages to La Planche des Belles Filles and the Col du Granon, where the Colombian was the only rider able to stay within a minute of the rampant Jonas Vingegaard.
The controversial painkiller was banned by the UCI in 2019, but is not currently on WADA’s list of performance enhancing substances (which may prove interesting if Quintana chooses to appeal his sanction).
In 2016, disgraced former Team Sky pro Jonathan Tiernan-Locke claimed that British Cycling “freely offered” tramadol to the country’s riders at the 2012 UCI Road World Championships.
The Movement for Credible Cycling (MPCC) – a voluntary organisation adhering to stricter anti-doping guidelines and of which Arkéa–Samsic are part – has been campaigning since 2013 for tramadol to be banned, claiming that its painkilling effects have led to an increase in crashes in the peloton.
Controversies concerning suspected doping practices have dogged Quintana in recent years since his move to Arkéa–Samsic from Movistar, where he achieved his grand tour successes.
> Two in custody as Arkea-Samsic manager distances team from doping probe
Quintana’s hotel room was searched at the 2020 Tour de France, while two members of his French team were taken into custody as part of an anti-doping investigation. The team distanced itself from the raid, claiming that it was aimed at “a very limited number of riders, as well as their close entourage”, and Quintana denied any wrongdoing after no illegal substances were found.
With the 32-year-old set to start the Vuelta on Friday, this week’s positive test will not, however, result in a ban, as tests for tramadol form part of the UCI’s medical checks and do not constitute an anti-doping rule violation.
Quintana’s results at the Tour, however, will be stripped, unless he successfully appeals.
(Think of the whole thing like the old haematocrit tests of the 1990s, used to ascertain whether a rider was taking EPO, but unable to prove much beyond the rider’s often ridiculous percentage of red blood cells. Marco Pantani most famously failed that test when he seemed poised to win the 1999 Giro d’Italia. While he had to leave the Cora Rosa, Il Pirata was only ‘banned’ from racing for two weeks and never – officially anyway – tested positive.)
Trek-Segafredo’s Toms Skujiņš tweeted his annoyance that Quintana’s positive test was once again bringing the sport into disrepute, but seemed happy with his belated elevation to the lofty GC heights of 60th at the Tour:
Cycling author Peter Cossins was one of those questioning Quintana’s future at Arkéa–Samsic, despite his scheduled appearance in Utrecht on Friday:
One Twitter personality, however, is unsurprisingly sticking by Nairoman, through thick and thin: